Stocks and Investing Stocks and Investing
Mon, May 8, 2023

Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $106 on, May 8th, 2023


Published on 2024-10-28 03:29:10 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $88 to $106 on, May 8th, 2023.

Yigal has made no other calls on APLS in the last 4 months.



There are 9 other peers that have a rating on APLS. Out of the 9 peers that are also analyzing APLS, 3 agree with Yigal's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Maintained at Hold with Increased Target to $76 on, Friday, May 5th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, April 17th, 2023


These are the ratings of the 6 analyists that currently disagree with Yigal


  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $100 on, Friday, May 5th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $110 on, Friday, May 5th, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $156 on, Friday, May 5th, 2023
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $75 on, Tuesday, February 21st, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Increased Target to $105 on, Tuesday, February 21st, 2023
Contributing Sources